Vimarsana
Biggest News Aggregation in the World

Aditya Gaur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aditya Gaur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aditya Gaur Today - Breaking & Trending Today

Experts weigh in on increase of HIV cases among teens | Health - Vimarsana News

Experts weigh in on increase of HIV cases among teens | Health

The Shelby County Health Department is urging people to get tested for HIV after they say there's been an 'alarming' increase in community infection rates.

UK Pharmacy dean continuing work with promising anti-malarial drug - Vimarsana News

UK Pharmacy dean continuing work with promising anti-malarial drug

Malaria is a life-threatening disease spread between humans by some types of mosquitoes that is mostly found in tropical countries. UK College of Pharmacy Dean Kip Guy, Ph.D., has researched this disease for nearly two decades. His current work is focused on researching treatments for malaria to help underserved populations, and understanding how this tropical parasitic disease is like one of Kentucky's most pressing health problems: cancer.

Source: uky.edu
Capable but unemployed spouse can't saddle partner with expenses: Delhi HC | Latest News Delhi - Vimarsana News

Capable but unemployed spouse can't saddle partner with expenses: Delhi HC | Latest News Delhi

Noting that the wife was voluntarily working as a social worker despite being a graduate, the court said the Hindu Marriage Act, 1955, maintenance provisions are gender-neutral | Latest News Delhi

Clifford Chance advises Actis on Emicool stake purchase deal - Vimarsana News

Clifford Chance advises Actis on Emicool stake purchase deal

Leading international law firm Clifford Chance has advised Actis, a global investor in sustainable infrastructure, on its entry into a share purchase deal to acquire a 50% stake in Emicool from Dubai Investments at an enterprise value of $1 billion.

Common cold coronaviruses hinder antibody immune response to SARS-CoV-2 infection - Vimarsana News

Common cold coronaviruses hinder antibody immune response to SARS-CoV-2 infection

Maureen McGargill, Ph.D., Department of Immunology, and graduate student Chun-Yang Lin. Prior infection with coronaviruses that cause the common cold